Bennett M R
British Heart Foundation Sr. Fellow, Addenbrooke's Hospital, Department of Medicine, Cambridge, UK.
Cardiovasc Res. 1999 Feb;41(2):361-8. doi: 10.1016/s0008-6363(98)00212-0.
Apoptosis (programmed cell death) of vascular smooth muscle cells (VSMCs) has recently been identified as an important process in a variety of human vascular diseases, including atherosclerosis, arterial injury, and restenosis after angioplasty. VSMC apoptosis is regulated by interactions between the local cell-cell and cytokine environment within the arterial wall, and the expression of pro- and anti-apoptotic proteins by the cell, including death receptors, proto-oncogenes and tumour suppressor genes. This review summarises our current knowledge of the occurrence and mechanisms underlying VSMC apoptosis in atherosclerosis and arterial remodelling.